Epidemiology Practice Questions

Q: All of the following infections have carrier states, EXCEPT:

Measles. **Explanation:** The concept of a **carrier state** refers to an individual who harbors a specific infectious agent without having clinical disease but serves as a potential source of infection for others. **1. Why Measles is the Correct Answer:** Measles is caused by a highly contagious virus that follows an **"all-or-none" phenomenon**. Once infected, an individual either develops the clinical disease or gains lifelong immunity. There is **no chronic or subclinical carrier state** in Measles. Furthermore, the virus does not persist in the body after the acute phase (except in the rare, late-onset complication of SSPE, which is not considered a carrier state for transmission). **2. Analysis of Incorrect Options:** * **Diphtheria:** Known for having both **convalescent and healthy carriers**. Carriers are more common than clinical cases and are significant reservoirs for spreading the infection in the community. * **Typhoid (Enteric Fever):** Famous for the **chronic carrier state** (e.g., "Typhoid Mary"). The bacteria (*S. typhi*) can persist in the gallbladder or biliary tract for years, shedding the organism in feces. * **Gonorrhea:** Frequently presents with **asymptomatic/subclinical carriers**, especially in females. These individuals do not show symptoms but can transmit the infection to sexual partners. **High-Yield Clinical Pearls for NEET-PG:** * **Diseases with NO carrier state:** Measles, Pertussis, Rabies, Smallpox, and Plague. * **Epidemiological Importance:** Diseases without a carrier state are generally easier to eradicate (e.g., Smallpox) because there is no "hidden" reservoir in the population. * **Incubatory Carrier:** Someone who sheds the pathogen during the incubation period (e.g., Measles, Mumps, Polio, Hepatitis B). Note: While Measles has an *incubatory* phase of shedding, it does not have a *chronic* carrier state.

Q: Which of the following is not a live attenuated vaccine?

Pertussis vaccine. The correct answer is **D. Pertussis vaccine**. ### **Explanation** The classification of vaccines is a high-yield topic in NEET-PG. Vaccines are broadly categorized into live attenuated, killed (inactivated), toxoids, and subunit vaccines. 1. **Why Pertussis is the correct answer:** The Pertussis vaccine is a **killed (inactivated) vaccine**. In the traditional DPT (Diphtheria, Pertussis, Tetanus) vaccine, the pertussis component consists of whole-cell killed *Bordetella pertussis*. Modern acellular pertussis (aP) vaccines are subunit vaccines containing purified antigens. It is never administered as a live attenuated preparation. 2. **Why other options are incorrect:** * **Polio Sabin (Option A):** This is the Oral Polio Vaccine (OPV), which is a classic **live attenuated** vaccine. In contrast, the Salk vaccine (IPV) is killed. * **Schwarz Measles (Option B):** The Schwarz strain is a standard **live attenuated** strain used globally for measles immunization. * **BCG (Option C):** Bacillus Calmette–Guérin is a **live attenuated** bacterial vaccine derived from *Mycobacterium bovis*. ### **High-Yield Clinical Pearls for NEET-PG** * **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **T**o **S**ite **V**ia **I**njection" (**B**CG, **R**otavirus, **G**umbaro/not human, **M**MR, **L**ive Typhoid/Ty21a, **T**ularemia, **S**mallpox, **V**aricella, **I**nfluenza/Nasal). * **Yellow Fever:** Uses the **17D strain**, which is live attenuated. * **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except HIV patients before the symptomatic stage for certain vaccines like BCG/Measles). * **Storage:** Most live vaccines are heat-sensitive and must be stored in the lower part of the refrigerator (2°C to 8°C) or frozen (OPV).

Q: In a population of 100,000 individuals surveyed over one year, 100 cases tested positive for malaria on a thick smear. Among these positive cases, 20 developed complications and 10 died. What is the Annual Parasite Incidence (API)?

1 per 1000. ### Explanation **1. Why Option A is Correct:** The **Annual Parasite Incidence (API)** is a key epidemiological indicator used under the National Vector Borne Disease Control Programme (NVBDCP) to measure the incidence of malaria in a community. It is calculated using the formula: $$\text{API} = \frac{\text{Total number of positive slides (confirmed cases) during the year}}{\text{Total population under surveillance}} \times 1000$$ **Calculation:** * Total positive cases = 100 * Total population = 100,000 * $\text{API} = (100 / 100,000) \times 1000 = \mathbf{1 \text{ per } 1000}$ **2. Why Other Options are Incorrect:** * **Option B (2 per 1000):** This value would result if there were 200 positive cases. It does not reflect the data provided. * **Option C (10 per 1000):** This is a mathematical distractor. * **Option D (20 per 1000):** This incorrectly uses the number of complications (20) as the numerator. The number of complications is used to calculate morbidity rates, not API. **Note on Mortality:** The 10 deaths mentioned in the question would be used to calculate the **Case Fatality Rate** (Deaths/Cases × 100 = 10%), which is a measure of disease severity, not incidence. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **API Significance:** An API of **$\geq$ 2** is the threshold used to classify an area as "high risk," requiring intensified indoor residual spraying (IRS). * **ABER (Annual Blood Examination Rate):** Measures the efficiency of surveillance. It should ideally be **$\geq$ 10%**. * **Slide Positivity Rate (SPR):** (Total positive slides / Total slides examined) × 100. * **Gold Standard:** While Rapid Diagnostic Tests (RDTs) are common, the **thick smear** remains the gold standard for parasite detection/quantification in epidemiological surveys.

Q: Which statement is false regarding cohort studies?

Always prospective. **Explanation:** In epidemiology, a **Cohort Study** is an observational analytical study where a group of individuals (the cohort) is defined based on the presence or absence of exposure to a particular factor and followed over time to observe the development of an outcome. **Why Option D is the Correct Answer (The False Statement):** While most cohort studies are prospective, they are **not always prospective**. Cohort studies can be classified into three types: 1. **Prospective Cohort:** Starts in the present and follows subjects into the future. 2. **Retrospective (Historical) Cohort:** Uses past records (e.g., medical files from 10 years ago) to identify exposure and follows the timeline forward to the present to see the outcome. 3. **Ambispective Cohort:** Combines both retrospective and prospective elements. **Analysis of Other Options:** * **A. Incidence can be measured:** This is a hallmark of cohort studies. Since we start with disease-free individuals and follow them over time, we can calculate the number of *new cases* (Incidence). * **B. Used to study chronic diseases:** Cohort studies are excellent for studying chronic conditions or diseases with long induction periods, provided the researcher has the resources for long-term follow-up. * **C. Expensive:** Because they require large sample sizes and long follow-up periods (often years), they are significantly more expensive and time-consuming than case-control studies. **High-Yield NEET-PG Pearls:** * **Directionality:** Cohort studies move from **Cause to Effect** (Forward-looking). * **Risk Assessment:** The primary measure of association in a cohort study is **Relative Risk (RR)** and **Attributable Risk (AR)**. * **Best For:** Studying **rare exposures** (e.g., a specific chemical leak) rather than rare diseases. * **Selection Bias:** Cohort studies are prone to **"Loss to follow-up"** (attrition bias).

Q: All of the following are true about Typhoid EXCEPT:

The highest incidence occurs in the 30-40 years age group. **Explanation:** The correct answer is **D**. In endemic areas like India, Typhoid fever (Enteric fever) primarily affects children and young adults. The highest incidence is typically observed in the **5-19 years age group**, not the 30-40 years group. By the fourth decade of life, many individuals have acquired natural immunity through repeated subclinical exposures. **Analysis of other options:** * **Option A:** The incubation period for *Salmonella typhi* is classically **10 to 14 days**, though it can range from 3 to 21 days depending on the host's health and the size of the infectious dose. * **Option B:** Epidemiological data consistently shows that Typhoid is **more common among males**. This is often attributed to greater outdoor activity, increased consumption of street food, and higher exposure to contaminated water sources. * **Option C:** **Ampicillin** (often combined with Probenecid) or Amoxicillin for 4–6 weeks is a standard treatment for the biliary carrier state, provided the gallbladder is not diseased. (Note: Ciprofloxacin is also used, but Ampicillin remains a textbook-correct option for carriers). **High-Yield Clinical Pearls for NEET-PG:** * **Reservoir:** Man is the only known reservoir. * **Chronic Carrier:** Defined as an individual excreting bacilli for **more than one year**. The most famous example is "Typhoid Mary." * **Nidus of Infection:** In chronic carriers, the organism persists in the **gallbladder** (associated with gallstones) or the urinary tract (associated with *Schistosoma haematobium*). * **Diagnostic Timelines:** Use the **BASU** mnemonic: **B**lood culture (1st week), **A**ntibody/Widal (2nd week), **S**tool culture (3rd week), **U**rine culture (4th week).

Q: The person, animal, object, or substance from which an infectious agent passes or is disseminated by a host is called what?

Source. ### Explanation The correct answer is **Source**. In epidemiology, it is crucial to distinguish between where an agent normally lives and where it actually comes from to infect a host. **1. Why "Source" is correct:** The **Source of infection** is defined as the person, animal, object, or substance from which an infectious agent passes directly to a host. It represents the "immediate" origin of the infection. For example, in a food poisoning outbreak caused by contaminated salad, the salad is the *source*, even if the *reservoir* of the bacteria is a human carrier who prepared it. **2. Why other options are incorrect:** * **Reservoir:** This is the natural habitat (human, animal, or environmental) in which an infectious agent lives, grows, and multiplies. While the source and reservoir can be the same (e.g., in Syphilis, a human is both), they are often different (e.g., in Hookworm, the reservoir is man, but the source is the soil). * **Carrier:** A carrier is an infected person or animal that harbors a specific infectious agent without having clinical disease and serves as a potential source of infection. It is a *type* of reservoir, not the definition of the dissemination point itself. * **Homologous reservoir:** This is a distractor term. In epidemiology, we generally classify reservoirs as Human, Animal, or Non-living. **Clinical Pearls for NEET-PG:** * **Source = Reservoir:** Occurs in diseases like Measles, Mumps, and STIs where there is no environmental stage or animal vector. * **Source ≠ Reservoir:** Occurs in Hookworm (Reservoir: Man; Source: Soil) and Tetanus (Reservoir: Soil; Source: Contaminated object). * **Case vs. Carrier:** A 'Case' shows clinical symptoms; a 'Carrier' does not but can still spread the disease. Carriers are often more dangerous epidemiologically because their activities are not restricted by illness.

Q: Severity of disease is assessed by:

Case fatality rate. **Explanation:** The severity of a disease is best reflected by its **Case Fatality Rate (CFR)**. CFR measures the proportion of people diagnosed with a specific disease who die from it within a specified period. Mathematically, it is (Total deaths from disease / Total diagnosed cases) × 100. It serves as an index of the **virulence** of an infectious agent and the killing power of a disease. **Analysis of Options:** * **Case Fatality Rate (Correct):** It directly quantifies the risk of dying once the disease is contracted. A high CFR (e.g., Rabies ~100%, Ebola ~50%) indicates a highly severe disease. * **Secondary Attack Rate (SAR):** This measures the **communicability** or infectivity of a disease within a closed group (like a household) after the introduction of a primary case. It does not reflect clinical severity. * **Incidence Rate:** This measures the number of **new cases** occurring in a population at risk during a specific period. It reflects the rate of transmission and risk of acquisition, not the outcome or severity. * **Prevalence Rate:** This measures the **total number of cases** (old + new) in a population at a given point in time. It is influenced by both incidence and duration of the disease. **High-Yield NEET-PG Pearls:** * **CFR** is a ratio, but traditionally expressed as a percentage. * **CFR is inversely related to prognosis:** Higher CFR means a poorer prognosis. * **Virulence** is clinically measured by CFR. * **Pathogenicity** is the ability of an agent to produce visible clinical disease (not necessarily death).

Q: If the same individual participates in both the study and experimental group (i.e., the patient serves as their own control), what is this design called?

Crossover study. ### Explanation **Correct Answer: A. Crossover study** In a **Crossover Study**, each participant receives two or more treatments in a specific sequence. The key feature is that **the patient serves as their own control**. This design eliminates "inter-individual variation" (differences between people) because the baseline characteristics (genetics, age, lifestyle) remain identical for both the treatment and control phases. Typically, a **washout period** is included between the two phases to ensure that the effects of the first drug are completely eliminated before the second drug is administered, preventing a "carry-over effect." **Why other options are incorrect:** * **B. Case-control study:** This is a retrospective observational study that compares individuals with a disease (cases) to those without (controls) to look for prior exposure. The groups consist of different individuals. * **C. Cohort study:** This is a longitudinal observational study where a group is followed forward in time to see who develops the outcome. It compares exposed vs. unexposed groups, not the same individual against themselves. * **D. Experimental study:** While a crossover study is a *type* of experimental study (specifically an RCT), "Experimental study" is a broad category. The question asks for the specific design where the patient is their own control, making "Crossover study" the most precise answer. **High-Yield Clinical Pearls for NEET-PG:** * **Advantage:** Requires a **smaller sample size** than a parallel-group RCT to achieve the same statistical power. * **Limitation:** It cannot be used for conditions that are "cured" by the first treatment (e.g., acute infections or surgeries) or for unstable/progressive diseases. * **Washout Period:** Essential to prevent the **Carry-over effect**. * **Statistical Test:** Since the data is paired (same person), a **Paired t-test** is often used for analysis.

Question 1

What is the most important factor for a test to be considered a good screening test?

Accepted Answer

Sensitivity

Answer

Specificity

Answer

Reliability

Answer

Predictive value

Question 2

All of the following infections have carrier states, EXCEPT:

Accepted Answer

Measles

Answer

Diphtheria

Answer

Typhoid

Answer

Gonorrhea

Question 3

Which of the following is not a live attenuated vaccine?

Accepted Answer

Pertussis vaccine

Answer

Polio Sabin vaccine

Answer

Schwarz measles vaccine

Answer

BCG vaccine

Question 4

In a population of 100,000 individuals surveyed over one year, 100 cases tested positive for malaria on a thick smear. Among these positive cases, 20 developed complications and 10 died. What is the Annual Parasite Incidence (API)?

Accepted Answer

1 per 1000

Answer

2 per 1000

Answer

10 per 1000

Answer

20 per 1000

Question 5

Which statement is false regarding cohort studies?

Accepted Answer

Always prospective

Answer

Incidence can be measured

Answer

Used to study chronic diseases

Answer

Expensive

Question 6

All of the following are true about Typhoid EXCEPT:

Accepted Answer

The highest incidence occurs in the 30-40 years age group

Answer

Incubation period is 10 to 14 days

Answer

It is most common among males

Answer

Carriers can be treated by Ampicillin

Question 7

The person, animal, object, or substance from which an infectious agent passes or is disseminated by a host is called what?

Accepted Answer

Source

Answer

Reservoir

Answer

Carrier

Answer

Homologous reservoir

Question 8

Severity of disease is assessed by:

Accepted Answer

Case fatality rate

Answer

Secondary attack rate

Answer

Prevalence rate

Answer

Incidence rate

Question 9

If the same individual participates in both the study and experimental group (i.e., the patient serves as their own control), what is this design called?

Accepted Answer

Crossover study

Answer

Case-control study

Answer

Cohort study

Answer

Experimental study

Question 10

All of the following factors contribute to the resurgence of malaria, except:

Accepted Answer

Drug resistance in the host

Answer

Drug resistance in the parasite

Answer

Drug resistance in vectors

Answer

Antigenic variations in the parasite

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?